| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 56.634 | 61.989 | 35.565 | 11.361 | 8.310 | 27.967 | 18.936 | 30.955 | 27.421 | 25.924 |
| Total Income - EUR | 56.643 | 62.641 | 36.705 | 11.367 | 8.583 | 27.967 | 18.937 | 30.956 | 27.421 | 25.950 |
| Total Expenses - EUR | 31.016 | 41.171 | 45.486 | 29.188 | 18.150 | 27.205 | 25.853 | 18.851 | 20.438 | 28.760 |
| Gross Profit/Loss - EUR | 25.627 | 21.469 | -8.782 | -17.821 | -9.567 | 762 | -6.917 | 12.105 | 6.983 | -2.811 |
| Net Profit/Loss - EUR | 23.928 | 20.850 | -9.149 | -17.934 | -9.653 | 488 | -7.106 | 11.795 | 6.709 | -2.811 |
| Employees | 5 | 6 | 6 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medirox Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 122 | 933 | 635 | 346 | 68 | 0 | 0 | 0 | 1.353 | 1.002 |
| Current Assets | 54.444 | 43.377 | 35.956 | 17.194 | 2.396 | 4.697 | 1.714 | 4.998 | 10.191 | 10.580 |
| Inventories | 0 | 566 | 0 | 88 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 14.067 | 24.047 | 5.557 | 14.762 | 1.350 | 657 | 873 | 3.958 | 9.511 | 5.622 |
| Cash | 40.377 | 18.765 | 30.398 | 2.344 | 1.046 | 4.040 | 841 | 1.040 | 679 | 4.958 |
| Shareholders Funds | 49.846 | 20.894 | 11.392 | -6.752 | -16.274 | -15.478 | -22.241 | -10.514 | -3.774 | -6.563 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.720 | 23.416 | 25.199 | 24.295 | 18.742 | 20.201 | 23.982 | 15.663 | 15.454 | 18.145 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medirox Srl